Rebecca K. Senter
Verve Therapeutics (United States)
ORCID: 0000-0001-5650-1187Biochemistry, Genetics and Molecular BiologyNeuroscienceMedicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: βSelective inhibition of glycogen synthase kinase 3Ξ± corrects pathophysiology in a mouse model of fragile X syndromeβ.
61 citations
Laura J. Stoppel, Rebecca K. Senter, Michael C. Lewis, Arnold J. Heynen, David C. Stoppel +12 more
23 citations
Nicole M. Fisher, Shalini Dogra, Rebecca K. Senter, Carson W. Reed, Jacob J. Kalbfleisch +6 more